Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 2Phase 1 2Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Pleural Malignancy 1Melanoma 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Ultraviolet Therapy × Clear all
NCT07628894 2026-06-05

Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy

City of Hope Medical Center

Phase 1 Not yet recruiting
8 enrolled
Dermatologic

Melanoma

NCT01673074 2020-04-08

HPPH and PDT for Pleural Malignancy

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
37 enrolled
Thoracic

Pleural Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡